Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
Delayed Nasdaq  -  04:00 2022-09-29 pm EDT
39.60 USD   -1.57%
09/19Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone
BU
09/12Transcript : Sage Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 03:40 PM
CI
09/05Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SAGE THERAPEUTICS, INC.
09/19Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating ..
BU
09/12Transcript : Sage Therapeutics, Inc. Presents at Morgan Stanley 20th Annual G..
CI
09/05Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
AQ
09/02Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
BU
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ra..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Ratin..
MT
08/02Transcript : Sage Therapeutics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02Sage Therapeutics Widens Q2 Net Loss as Revenue Declines
MT
08/02Sage Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months ..
CI
08/02Sage Therapeutics : Announces Second Quarter 2022 Financial Results and Highlights Pipelin..
PU
08/02Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeli..
BU
08/01Sage Therapeutics to Present at Upcoming August Investor Conferences
BU
07/19Sage Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 2,..
BU
07/14Sage Therapeutics : IF YOU DO NOT OBJECT TO THE PROPOSED SETTLEMENT, OR THE AGREED-TO ATTO..
PU
More most relevant news
All news about SAGE THERAPEUTICS, INC.
09/19Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating ..
BU
09/12Transcript : Sage Therapeutics, Inc. Presents at Morgan Stanley 20th Annual G..
CI
09/05Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
AQ
09/02Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
BU
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ra..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Ratin..
MT
08/02Transcript : Sage Therapeutics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02Sage Therapeutics Widens Q2 Net Loss as Revenue Declines
MT
08/02SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
More news
News in other languages on SAGE THERAPEUTICS, INC.
08/02Sage Therapeutics creuse sa perte nette au 2e trimestre et voit ses revenus diminuer
08/02Sage Therapeutics, Inc. annonce ses résultats financiers pour le deuxième trimestre et ..
06/13Sage Therapeutics, Inc. fournit une mise à jour sur la demande de nouveau médicament po..
06/01Le médicament de Sage-Biogen améliore les symptômes dans une étude sur la dépression po..
06/01Sage Therapeutics et Biogen annoncent que l'étude de phase 3 SKYLARK sur la Zuranolone ..
06/01USA-Les valeurs à suivre à Wall Street (actualisé)
05/09Achat d'initiés : Sage Therapeutics
05/03Sage Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars..
05/03Sage Therapeutics nomme Mark Pollack au poste de vice-président principal des affaires ..
05/02Sage et Biogen commencent à soumettre à la FDA américaine une demande d'autorisation de..
More news
Analyst Recommendations on SAGE THERAPEUTICS, INC.
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ra..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Ratin..
MT
07/11SVB Securities Adjusts Sage Therapeutics' Price Target to $40 from $50, Keeps Market Pe..
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcar..
MT
More recommendations
Press releases
09/19Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating ..
BU
09/05Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
AQ
09/02Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
BU
08/02SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
08/02Sage Therapeutics : Announces Second Quarter 2022 Financial Results and Highlights Pipelin..
PU
More press releases
Upcoming event on SAGE THERAPEUTICS, INC.